BIOR(Delisted)
Biora Therapeutics·NASDAQ
--
--(--)
Signals Analysis
Bullish signal 0
Bearish signal 1
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About BIOR
Biora Therapeutics, Inc.
A company that provides molecular and professional diagnostic solutions for prenatal care and treatment of cancer
4330 La Jolla Village Drive, Suite 300, San Diego, CA 92122
--
Biora Therapeutics, Inc., was incorporated in Delaware in January 2012. The company is a biotechnology company with an established track record of success in the development and commercialization of molecular detection products and innovation in the field of precision medicine. The company adopts a multi-omics approach, combining genomics, epigenomics, proteomics and metabolomics into molecular detection products, and develops a suite of investigational ingestible devices and drug combinations designed to provide precise diagnostic sampling and drug delivery solutions.
Company Financials
EPS
BIOR has released its 2024 Q3 earnings. EPS was reported at -6.08, versus the expected -3.85, missing expectations. The chart below visualizes how BIOR has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
BIOR has released its 2024 Q3 earnings report, with revenue of 32.00K, reflecting a YoY change of NaN%, and net profit of -18.40M, showing a YoY change of 74.95%. The Sankey diagram below clearly presents BIOR's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
You can ask Aime
No Data
